AM-201

N/A

Report date: 2023/02/11 20:37:32

Base Information

Drug NameAM-201

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionTumor necrosis factor α inhibitorsInterleukin-6 inhibitors

TargetsTumor necrosis factor αInterleukin-6

Therapy Area/IndicationsPsoriasisArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAbclon Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAbclon Inc

Active IndicationsN/A

Inactive IndicationsPsoriasisArthritis, Rheumatoid

Other Information

ATC CodeN/A